These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 26308588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes of specialized residential treatment for adults with obsessive-compulsive disorder.
    Björgvinsson T, Hart AJ, Wetterneck C, Barrera TL, Chasson GS, Powell DM, Heffelfinger S, Stanley MA.
    J Psychiatr Pract; 2013 Sep; 19(5):429-37. PubMed ID: 24042250
    [Abstract] [Full Text] [Related]

  • 3. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D, Naismith I, Miles S, Childs G, Ball J, Muccio F, Darnley S.
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [Abstract] [Full Text] [Related]

  • 4. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders.
    Simpson HB, Wetterneck CT, Cahill SP, Steinglass JE, Franklin ME, Leonard RC, Weltzin TE, Riemann BC.
    Cogn Behav Ther; 2013 May; 42(1):64-76. PubMed ID: 23316878
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictors of acute outcomes for intensive residential treatment of obsessive-compulsive disorder.
    Siwiec SG, Riemann BC, Lee HJ.
    Clin Psychol Psychother; 2019 Nov; 26(6):661-672. PubMed ID: 31273851
    [Abstract] [Full Text] [Related]

  • 7. How willing are you? Willingness as a predictor of change during treatment of adults with obsessive-compulsive disorder.
    Reid AM, Garner LE, Van Kirk N, Gironda C, Krompinger JW, Brennan BP, Mathes BM, Monaghan SC, Tifft ED, André MC, Cattie J, Crosby JM, Elias JA.
    Depress Anxiety; 2017 Nov; 34(11):1057-1064. PubMed ID: 28715850
    [Abstract] [Full Text] [Related]

  • 8. Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.
    van Oppen P, van Balkom AJ, Smit JH, Schuurmans J, van Dyck R, Emmelkamp PM.
    J Clin Psychiatry; 2010 Sep; 71(9):1158-67. PubMed ID: 20361906
    [Abstract] [Full Text] [Related]

  • 9. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ, Waters AM, Boschen MJ, Hattingh L, McConnell H, Milliner EL, Collings N, Zimmer-Gembeck M, Shelton D, Ollendick TH, Testa C, Storch EA.
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effectiveness of cognitive-behavioral therapy in children and adolescents with obsessive-compulsive disorders treated in an outpatient clinic].
    Beig I, Döpfner M, Goletz H, Plück J, Dachs L, Kinnen C, Walter D.
    Z Kinder Jugendpsychiatr Psychother; 2017 Aug; 45(3):219-235. PubMed ID: 27058836
    [Abstract] [Full Text] [Related]

  • 12. Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy.
    Motivala SJ, Arellano M, Greco RL, Aitken D, Hutcheson N, Tadayonnejad R, O'Neill J, Feusner JD.
    Int J Psychiatry Clin Pract; 2018 Mar; 22(1):40-46. PubMed ID: 28691550
    [Abstract] [Full Text] [Related]

  • 13. Evidence for successful implementation of exposure and response prevention in a naturalistic group format for pediatric OCD.
    Olino TM, Gillo S, Rowe D, Palermo S, Nuhfer EC, Birmaher B, Gilbert AR.
    Depress Anxiety; 2011 Apr; 28(4):342-8. PubMed ID: 21456041
    [Abstract] [Full Text] [Related]

  • 14. Does Exposure and Response Prevention Behaviorally Activate Patients With Obsessive-Compulsive Disorder? A Preliminary Test.
    Blakey SM, Abramowitz JS, Leonard RC, Riemann BC.
    Behav Ther; 2019 Jan; 50(1):214-224. PubMed ID: 30661561
    [Abstract] [Full Text] [Related]

  • 15. Metacognitive therapy versus exposure and response prevention for obsessive-compulsive disorder: study protocol for a randomized controlled trial.
    Melchior K, Franken I, Deen M, van der Heiden C.
    Trials; 2019 May 20; 20(1):277. PubMed ID: 31109349
    [Abstract] [Full Text] [Related]

  • 16. Are all safety behaviours created equal? A comparison of novel and routinely used safety behaviours in obsessive-compulsive disorder.
    Levy HC, Radomsky AS.
    Cogn Behav Ther; 2016 Sep 20; 45(5):367-79. PubMed ID: 27243978
    [Abstract] [Full Text] [Related]

  • 17. Empirically-derived response trajectories of intensive residential treatment in obsessive-compulsive disorder: A growth mixture modeling approach.
    Falkenstein MJ, Nota JA, Krompinger JW, Schreck M, Garner LE, Potluri S, Van Kirk N, Ponzini G, Tifft E, Brennan BP, Mathes B, Cattie J, Crosby JM, Elias JA.
    J Affect Disord; 2019 Feb 15; 245():827-833. PubMed ID: 30699866
    [Abstract] [Full Text] [Related]

  • 18. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.
    Stewart SE, Yen CH, Stack DE, Jenike MA.
    J Psychiatr Res; 2006 Sep 15; 40(6):511-9. PubMed ID: 16229857
    [Abstract] [Full Text] [Related]

  • 19. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.
    Am J Psychiatry; 2005 Jan 15; 162(1):151-61. PubMed ID: 15625214
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of intensive treatment services for obsessive compulsive disorder: outcomes from the first Canadian residential treatment program.
    Taube-Schiff M, Rector NA, Larkin P, Mehak A, Richter MA.
    Int J Psychiatry Clin Pract; 2020 Mar 15; 24(1):59-67. PubMed ID: 31670999
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.